Home › Therapeutic areas › Metabolic › Urea Cycle Disorders
Urea Cycle Disorders (2 companies)
Companies with an active program in Urea Cycle Disorders.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| DTIL | Precision Biosciences | Infectious DiseaseMetabolic+1 Rare | 1 | Phase 1 | $296M | 5 |
| RARE | Ultragenyx Pharmaceutical | CardiovascularMetabolic+1 Rare | 1 | Approved | $1.57B | 10 |
No companies match.